Clinical Trial Update: A Treatment Use Protocol for Subjects Continuing on From the Open-label Extension 0601 [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial update describes a treatment use protocol for subjects continuing from an open-label extension (0601) in epilepsy, complex partial seiz…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Complex Partial Seizures
• Epilepsy

Drugs mentioned

• Marinus Pharmaceuticals

Snippet

Sponsor: Marinus Pharmaceuticals | Conditions: Epilepsy, Complex Partial | Phase 2 | Status: COMPLETED | Results posted: 2022-09-07